Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
35
GPRE Quote, Financials, Valuation and Earnings
Last price:
$9.40
Seasonality move
:
3.12%
Day range:
$9.12 - $9.48
52-week range:
$9.12 - $26.06
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.23x
P/B ratio:
0.66x
Volume:
2.5M
Avg. volume:
1.2M
1-year change:
-63.02%
Market cap:
$607.1M
Revenue:
$3.3B
EPS (TTM):
-$0.38
Earnings Data
Next earnings date for GPRE
Feb 07
2025
Most recent earnings per share
$0.69
Beat by $0.59
(Oct 31/2024)
Consensus Estimate
$0.10
(Oct 31/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GPRE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/07/2025 | Q4 | $646M | -- | -- | -$0.21 | -- |
| 10/31/2024 | Q3 | $667M | $658.7M | $0.69 | $0.10 | $0.59 |
| 08/06/2024 | Q2 | $651.2M | $618.8M | -$0.38 | -$0.25 | -$0.13 |
| 05/03/2024 | Q1 | $654.4M | $597.2M | -$0.81 | -$0.34 | -$0.47 |
| 02/07/2024 | Q4 | $782M | $712.4M | $0.12 | $0.16 | -$0.04 |
| 10/31/2023 | Q3 | -- | -- | $0.35 | -$0.14 | $0.49 |
| 08/04/2023 | Q2 | -- | -- | -$0.89 | -$0.05 | -$0.84 |
| 05/04/2023 | Q1 | -- | -- | -$1.20 | -$0.53 | -$0.67 |
| 02/08/2023 | Q4 | -- | -- | -$0.66 | -$0.24 | -$0.42 |
| 11/03/2022 | Q3 | -- | -- | -$1.27 | -$0.14 | -$1.13 |
| 08/02/2022 | Q2 | -- | -- | $0.73 | $0.14 | $0.59 |
| 05/02/2022 | Q1 | -- | -- | -$1.16 | -$0.31 | -$0.86 |
| 02/11/2022 | Q4 | -- | -- | -$0.18 | $0.26 | -$0.44 |
| 11/04/2021 | Q3 | -- | -- | -$1.18 | -$0.23 | -$0.95 |
| 08/02/2021 | Q2 | -- | -- | $0.20 | -$0.24 | $0.44 |
| 05/03/2021 | Q1 | -- | -- | -$0.17 | -$0.59 | $0.42 |
| 02/09/2021 | Q4 | -- | -- | -$1.43 | -$0.39 | -$1.04 |
| 11/04/2020 | Q3 | -- | -- | -$1.00 | -$0.28 | -$0.72 |
| 08/03/2020 | Q2 | -- | -- | -$0.24 | -$0.70 | $0.46 |
| 05/04/2020 | Q1 | -- | -- | -$0.47 | -$0.93 | $0.46 |
| 02/10/2020 | Q4 | -- | -- | -$1.13 | -$0.56 | -$0.57 |
| 11/05/2019 | Q3 | -- | -- | -$1.06 | -$1.12 | $0.05 |
| 08/05/2019 | Q2 | -- | -- | -$1.13 | -$0.83 | -$0.30 |
| 05/08/2019 | Q1 | -- | -- | -$1.06 | -$0.88 | -$0.18 |
| 02/11/2019 | Q4 | -- | -- | -$1.66 | -$0.51 | -$1.16 |
| 11/08/2018 | Q3 | -- | -- | -$0.31 | -$0.49 | $0.18 |
| 08/01/2018 | Q2 | -- | -- | -$0.02 | -$0.28 | $0.26 |
| 05/07/2018 | Q1 | -- | -- | -$0.60 | -$0.42 | -$0.19 |
| 02/08/2018 | Q4 | -- | -- | -$0.16 | -$0.19 | $0.03 |
| 11/02/2017 | Q3 | -- | -- | -$0.18 | -$0.02 | -$0.16 |
| 08/01/2017 | Q2 | -- | -- | -$0.41 | -$0.12 | -$0.30 |
| 05/02/2017 | Q1 | -- | -- | -$0.09 | -$0.19 | $0.10 |
| 02/09/2017 | Q4 | -- | -- | $0.47 | $0.36 | $0.11 |
| 11/01/2016 | Q3 | -- | -- | $0.20 | $0.27 | -$0.07 |
| 08/02/2016 | Q2 | -- | -- | $0.21 | -- | -- |
| 05/03/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/11/2016 | Q4 | -- | -- | -- | $0.23 | -- |
| 11/02/2015 | Q3 | -- | -- | $0.16 | $0.16 | -- |
| 07/29/2015 | Q2 | -- | -- | $0.19 | $0.44 | -$0.25 |
| 04/29/2015 | Q1 | -- | -- | -- | $0.14 | -- |
| 02/05/2015 | Q4 | -- | -- | $1.07 | $0.97 | $0.10 |
Green Plains Earnings Questions
-
How Much did Green Plains Generate in Revenue Last Quarter?
Green Plains reported $658.7M worth of top line sales in its most recent quarter.
-
Did Green Plains Beat Earnings Last Quarter?
Green Plains announced earnings per share of $0.69 which represents a beat of analyst forecast a $0.10 per share.
-
Is Green Plains Profitable?
Green Plains reported $78.1M that represents $1.09 per share over the last quarter.
-
What is the Analyst Consensus for Green Plains EPS Next Year?
Green Plains's earnings are forecast to decrease from -$1.59 per share to -$1.51 per share next year representing a decrease of -42.98%.
-
When is Green Plains's Earnings Date?
Green Plains's next earnings date is February 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
